Repeated administration of #COVID19 #boosters with very short intervals might reduce the level of antibodies that can be produced at each administration. #EMAPresser
— EU Medicines Agency (@EMA_News) January 18, 2022
Repeated administration of #COVID19 #boosters with very short intervals might reduce the level of antibodies that can be produced at each administration. #EMAPresser
— EU Medicines Agency (@EMA_News) January 18, 2022
